Outlook Therapeutics Ratios (2015-2025) | OTLK

1Y3Y5Y7Y10YAll
Download Data
Ratios Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin 70.78%1,098.52%
EBT Margin -2,971.87%-895.87%-3,647.43%-1,689.85%-350.98%-4,511.46%-2,135.40%-6,298.89%-2,654.21%-1,758.72%-202.47%-656.99%-976.81%-1,092.37%-1,644.94%-912.50%-1,597.90%-893.79%-217.47%1,469.33%818.80%1,416.97%-1,338.75%16,175.93%
EBIT Margin -2,829.23%-853.02%-3,510.23%-1,649.75%-296.91%-4,450.95%-2,011.04%-5,870.30%-2,585.60%-2,420.14%-100.29%-411.95%-884.97%-935.35%-1,608.21%-960.78%-1,201.86%-966.72%-216.83%1,369.33%971.59%2,677.76%-1,046.20%18,863.90%
EBITDA Margin -2,829.23%-853.02%-3,510.23%-1,649.75%-296.91%-4,450.95%-2,011.04%-5,870.30%-2,585.60%-2,420.14%-100.29%-411.95%-884.97%-935.35%-1,608.21%-960.78%-1,201.86%-966.72%-216.83%1,369.33%971.59%2,677.76%-1,046.20%18,863.90%
Operating Margin -2,829.23%-853.02%-3,510.23%-1,649.75%-296.91%-4,450.95%-2,011.04%-5,870.30%-2,585.60%-2,420.14%-100.29%-411.95%-884.97%-935.35%-1,608.21%-960.78%-1,201.86%-966.72%-216.83%1,369.33%971.59%2,677.76%-1,046.20%18,863.90%
Net Margin -3,047.83%-960.06%-3,692.45%-1,789.51%-459.63%-6,101.20%-2,135.40%-6,300.21%-2,654.21%-1,758.72%-260.16%-2,296.48%-1,108.74%-1,176.92%-1,638.80%-926.60%-1,760.92%-787.71%-175.25%3,091.65%2,508.02%679.60%-1,338.75%14,482.19%
FCF Margin -1,044.51%-2,891.14%-1,244.00%-704.72%-3,332.90%-2,161.82%-1,975.99%-1,370.32%-1,883.29%1.93%-1,262.64%-999.38%-1,127.54%-1,251.08%-974.82%-1,049.51%-1,757.27%-91.08%1,116.62%-790.61%13,484.70%
Efficiency
Inventory Average 3.36M3.87M3.73M3.40M
Assets Average 28.91M29.20M22.93M18.95M17.29M18.93M26.51M30.03M30.94M28.18M20.50M17.94M25.19M25.17M13.78M11.80M21.71M23.62M18.04M20.73M20.49M18.41M
Equity Average -18.15M-1.80M-13.50M-24.34M-27.90M-31.30M-29.37M-29.33M-23.38M-19.37M-25.95M-27.22M-17.32M-11.34M-23.53M-25.73M-4.78M-19.66M-41.38M-34.83M-34.69M-35.37M
Invested Capital -51.95M-35.32M3.93M-2.29M-16.90M-20.24M-17.41M-33.45M-12.90M-21.06M-0.36M-25.38M-17.30M-20.47M0.14M-9.43M-30.93M-20.52M10.97M-50.29M-32.46M-37.19M-32.19M-38.55M
Asset Utilization Ratio 0.100.100.100.080.080.200.160.160.170.110.170.180.120.320.470.440.19-0.07-0.060.050.070.08
Leverage & Solvency
Interest Coverage Ratio -19.83-19.91-25.58-41.14-5.49-73.56-16.17-36.38-6.30-4.20-1.36-4.43-7.42-6.29-11.23-9.15-7.31-5.22-60.39-13.69-9.72-26.78
Debt to Equity -0.07-0.020.48-0.55-0.23-0.25-0.40-0.39-0.49-0.38-0.98-0.01-0.35-0.27-1.03-0.420.000.000.05-0.65-0.55
Debt Ratio 0.100.030.020.110.250.390.680.640.380.450.380.010.490.450.200.390.000.000.021.100.91
Equity Ratio -1.57-1.520.05-0.20-1.07-1.54-1.69-1.62-0.78-1.21-0.39-1.15-1.41-1.64-0.20-0.94-2.97-1.560.36-2.96-1.70-1.66-1.73-2.11
Times Interest Earned -19.83-19.91-25.58-41.14-5.49-73.56-16.17-36.38-6.30-4.20-1.36-4.43-7.42-6.29-11.23-9.15-7.31-5.22-60.39-13.69-9.72-26.78
Valuation
Enterprise Value -0.43M-5.38M18.25M-5.58M14.55M-13.56M-2.35M-2.08M-0.08M-0.14M-3.19M-13.84M-5.94M-11.80M-1.72M-0.23M-0.16M-14.03M-8.02M-1.33M-4.65M-23.95M-5.70M-7.56M-8.90M-8.08M-8.68M
Return Ratios
Return on Sales -28.25%-9.05%-36.49%-16.95%-3.56%-45.12%-21.35%-63.00%-26.54%-17.59%-2.20%-2.49%-9.77%-10.92%-15.80%-9.13%-15.98%-7.61%-1.72%14.69%8.19%6.80%10.07%48.32%-13.39%144.82%-66.00%
Return on Capital Employed -9.84%-5.86%5.73%3.64%1.95%3.66%4.53%11.77%15.18%7.69%5.22%4.15%-18.24%-7.43%5.41%2.79%-12.15%5.78%4.35%2.26%1.92%
Return on Invested Capital 3.75%-62.66%5.50%3.10%2.28%1.43%0.82%1.06%1.70%2.05%3.43%7.01%6.50%0.85%1.51%
Return on Assets -2.10%-1.83%-2.42%-3.17%-2.49%-2.05%-0.82%-0.70%-0.78%-1.07%-1.85%-2.26%-1.45%-1.37%-2.44%-2.46%-1.27%-0.74%-3.05%-3.35%-3.90%-5.07%
Return on Equity 3.35%29.53%4.11%2.47%1.54%1.24%0.74%0.72%1.04%1.55%1.46%1.49%2.11%3.04%1.43%1.13%5.77%0.89%1.33%2.00%2.30%2.64%